Sign inJoin waitlistJoin the waitlist

Joanna Yi

Associate Director, Clinical and Experimental Therapeutics Research, Leukemia Program · Baylor College of Medicine

Credentials: · ·

History

Baylor College of Medicine
Present
Baylor College of Medicine
Present

Research

Catalytic site remodelling of the DOT1L methyltransferase by selective inhibitors
Nature Communications · 2012 · 243 citations
Phase II Trial of Inotuzumab Ozogamicin in Children and Adolescents With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia: Children's Oncology Group Protocol AALL1621
Journal of Clinical Oncology · 2022 · 118 citations
Tazemetostat for tumors harboring SMARCB1/SMARCA4 or EZH2 alterations: results from NCI-COG pediatric MATCH APEC1621C
Journal of the National Cancer Institute · 2023 · 97 citations

Karen Rabin
6 papers
Monica Gramatges
6 papers
Alexandra Stevens
5 papers
Etan Orgel
5 papers
Steven Mittelman
5 papers
VH
Van Huynh
5 papers
Branko Cuglievan
4 papers
Cesar Nunez
3 papers
Courtney DiNardo
3 papers
David McCall
3 papers · 1 as a fellow
JB
James Bradner
3 papers
Jonathan Pang
3 papers

Clinical trials

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2025–2028
Project: Every Child for Younger Patients With Cancer
Site PI · Recruiting
Children's Oncology Group
2015–2030